The global Life Sciences Customer Relationship Management (CRM) market is witnessing robust growth, valued at USD 1.24 billion in 2024, expected to reach USD 1.32 billion in 2025, and projected to grow to USD 2.29 billion by 2034. With a steady CAGR of 6.32% from 2025 to 2034, this sector is driven by digital-first engagement, AI integration, personalized medicine, and increasing demand for value-based care.
This article offers a deep dive into the segmental and regional insights of the market and highlights the leading companies shaping the life sciences CRM landscape.
2024 Market Size: USD 1.24 billion
Forecast for 2034: USD 2.29 billion
CAGR (2025–2034): 6.32%
North America: Dominated the market with a 45% revenue share in 2024.
Asia Pacific: Poised for the fastest growth over the forecast period.
Sales Force Automation (SFA): Held 39% market share in 2024.
Patient Engagement & Support Programs: Expected to register the fastest growth rate.
About: Veeva is a global leader in cloud-based software tailored to life sciences companies.
Products: Veeva CRM, Vault, and Commercial Cloud Suite.
Market Cap: Approx. USD 32 billion.
About: The world’s #1 CRM provider, Salesforce tailors solutions for healthcare and life sciences through Health Cloud.
Products: Salesforce Health Cloud, Einstein AI, and AppExchange integrations.
Market Cap: Approx. USD 270 billion.
About: A division of Oracle focused on data-driven clinical and commercial operations.
Products: Oracle Clinical One, Siebel CRM, and Oracle Health Sciences Cloud.
Market Cap: Approx. USD 350 billion.
About: IQVIA offers advanced analytics and technology solutions for life sciences.
Products: Orchestrated Customer Engagement, OCE CRM, and real-world evidence platforms.
Market Cap: Approx. USD 47 billion.
About: Microsoft’s CRM and ERP solutions tailored to healthcare provider and life sciences workflows.
Products: Dynamics 365 Sales, Customer Insights, and Healthcare Accelerator.
Market Cap: Approx. USD 3.5 trillion.
About: Zinfi focuses on Unified Channel Management and partner relationship tools.
Products: CRM for Life Sciences, Partner Relationship Management (PRM).
Market Cap: Privately held (undisclosed).
About: A Swiss company providing mobile CRM solutions for field teams in life sciences.
Products: Pitcher Super App for commercial excellence and sales enablement.
Market Cap: Privately held (undisclosed).
About: ACTO offers an AI-powered commercial learning platform for life sciences.
Products: ACTO Omnichannel Education Platform, CRM connectors.
Market Cap: Privately held (undisclosed).
About: Known for quote-to-cash automation and CLM software, supporting life sciences sales teams.
Products: Conga CRM integration, Apttus CPQ, CLM.
Market Cap: Privately held, post-merger with Conga (valued around USD 715 million).
About: Offers Salesforce-optimized CRM tools for verticals including life sciences.
Products: Sforce CRM extensions and life sciences modules.
Market Cap: Not publicly available.
About: A global SaaS company offering user-friendly CRM for SMEs and enterprises.
Products: Freshsales, Freshmarketer for life sciences field reps.
Market Cap: Approx. USD 3 billion.
About: French-based provider of healthcare-focused CRM and data solutions.
Products: Mobile Intelligence, OneKey database, and marketing automation tools.
Market Cap: Approx. USD 500 million.
About: A digital-first commercialization company focused on healthcare.
Products: CRM, omnichannel marketing, medical content platforms.
Market Cap: Estimated at USD 1 billion (private company).
About: A biopharmaceutical solutions company offering integrated life sciences services.
Products: Field deployment CRM, commercialization strategy tools.
Market Cap: Acquired by a private equity consortium in 2023 (deal valued at USD 7.1 billion).
About: A global consulting firm with strong life sciences CRM capabilities.
Products: CRM consulting, analytics platforms, and sales optimization tools.
Market Cap: Private partnership (est. revenue over USD 1 billion).
About: An India-based company offering industry-specific CRM platforms.
Products: CRM for Pharma Sales, Doctor engagement, distributor management.
Market Cap: Privately held (undisclosed).
About: Specializes in mobile sales force automation and CRM for consumer goods and life sciences.
Products: TouchRx, StayinFront EdgeRx.
Market Cap: Private company (global operations).
About: Specializes in medication safety analytics integrated with healthcare CRM.
Products: Data-driven CRM for pharmacy and hospital systems.
Market Cap: Privately held startup (early-stage growth).
Request a customized case study tailored to your business needs and gain deeper insights
into healthcare market strategies: sales@towardshealthcare.com
Life sciences CRM (Customer Relationship Management) systems manage interactions with healthcare professionals, patients, and stakeholders. It supports commercial operations, regulatory compliance, and patient engagement in pharma, biotech, and medical device sectors.
It facilitates drug launches, improves field sales productivity, ensures regulatory alignment, and enhances engagement through omnichannel strategies.
North America currently holds the largest share (~45%), driven by early tech adoption and strong healthcare infrastructure.
The Patient Engagement and Support Programs segment is expected to grow at the highest CAGR due to the increasing focus on personalized care and adherence.
Some of the top companies include Veeva Systems, Salesforce, Oracle, IQVIA, Microsoft, and Freshworks, along with several specialized providers like ACTO, Pitcher, and Cegedim.
Source : https://www.towardshealthcare.com/insights/life-sciences-crm-market-sizing
Invest in Our Premium Strategic Solution: https://www.towardshealthcare.com/price/5895
The global digital health and wellness market is projected to expand from US$ 498.99 billion in 2024 to US$ 3,568.11… Read More
The global radiopharmaceutical market is projected to grow from USD 6.8 billion in 2024 to USD 14.11 billion by 2034,… Read More
The U.S. life science market is on an upward trajectory, poised to generate substantial revenue growth, potentially climbing into the… Read More
The U.S. cell therapy market size is forecast to grow at a CAGR of 21.46%, from USD 8.04 billion in… Read More
The global animal biotechnology market was USD 28.17 billion in 2024, rose to USD 30.97 billion in 2025, and is… Read More
The global ophthalmology devices market was US$ 7.51 billion in 2024, rose to US$ 7.89 billion in 2025, and is… Read More